STEAP1 is associated with the invasive and oxidative stress phenotype of ewing tumors

Molecular Cancer Research

Volumn 10, Issue 1, 2012, Pages 52-65

  Grunewald, Thomas G P ^a,b,e   Diebold, Isabel ^c   Esposito, Irene ^a,d   Plehm, Stephanie ^a   Hauer, Kristina ^a   Thiel, Uwe ^a   Da Silva Buttkus, Patricia ^d   Neff, Frauke ^d   Unland, Rebekka ^f,g   Müller Tidow, Carsten ^f   Zobywalski, Colette ^a   Lohrig, Katharina ^h   Lewandrowski, Urs ^h   Sickmann, Albert ^h,i   Da Costa, Olivia Prazeres ^e   Görlach, Agnes ^c   Cossarizza, Andrea ^j   Butt, Elke ^k   Richter, Günther H S ^a   Burdach, Stefan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Medical Life Science and Technology Center   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k UNIVERSITY OF WÜRZBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; PROTEIN SIX TRANSMEMBRANE EPITHELIAL ANTIGEN PROSTATE 1; PROTEOME; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; COLONY FORMATION; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, NEOPLASM; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICROARRAY ANALYSIS; NEOPLASM INVASIVENESS; OXIDATIVE STRESS; OXIDOREDUCTASES; PHENOTYPE; PROTEOMICS; RNA, SMALL INTERFERING; SARCOMA, EWING;

EID: 84856006864     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0524     Document Type: Article

References (50)

1. Burdach S, Jurgens H. High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002;41: 169-89. (Pubitemid 34150128)
2. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts.NEngl JMed1994;331:294-9. (Pubitemid 24236016)
3. Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, Hansen G, et al. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 2004;64:8213-21. (Pubitemid 39491758)
4. Richter GH, Plehm S, Fasan A, Rössler S, Unland R, Bennani-Baiti IM, et al. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc Natl Acad Sci U S A 2009;106:5324-9.
5. Sendamarai AK, Ohgami RS, Fleming MD, Lawrence CM. Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle. Proc Natl Acad Sci U S A 2008;105:7410-5. (Pubitemid 351830031)
6. Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A 1999;96:14523-8. (Pubitemid 30000683)
7. Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are metalloreductases. Blood 2006;108:1388-94. (Pubitemid 44232042)
8. Vaghjiani RJ, Talma S, Murphy CL. Six-transmembrane epithelial antigen of the prostate (STEAP1 and STEAP2)-differentially expressed by murine and human mesenchymal stem cells. Tissue Eng Part A 2009;15:2073-83.
9. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007; 11:421-9. (Pubitemid 46680428)
10. Valenti MT, Dalle Carbonare L, Donatelli L, Bertoldo F, Giovanazzi B, Caliari F, et al. STEAP mRNA detection in serum of patients with solid tumours. Cancer Lett 2009;273:122-6.
11. Cheung IY, Feng Y, Danis K, Shukla N, Meyers P, Ladanyi M, et al. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clin Cancer Res 2007;13: 6978-83. (Pubitemid 350276878)
12. Challita-Eid PM, Morrison K, Etessami S, An Z, Morrison KJ, Perez-Villar JJ, et al.Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo. Cancer Res 2007;67:5798-805. (Pubitemid 46985013)
13. Sanchez-Pulido L, Rojas AM, Valencia A, Martinez AC, Andrade MA. ACRATA: a novel electron transfer domain associated to apoptosis and cancer. BMC Cancer 2004;4:98.
14. von Rozycki T, Yen MR, Lende EE, Saier MH Jr. The YedZ family: possible heme binding proteins that can be fused to transporters and electron carriers. J Mol Microbiol Biotechnol 2004;8: 129-40. (Pubitemid 41202237)
15. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-9. (Pubitemid 38339084)
16. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, et al. Identification of a ferrireductase required for efficient transferrin- dependent iron uptake in erythroid cells. Nat Genet 2005;37: 1264-9. (Pubitemid 41568711)
17. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794-8.
18. Grek CL, Tew KD. Redox metabolism and malignancy. Curr Opin Pharmacol 2010;10:362-8.
19. Smith DG, Magwere T, Burchill SA. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors. Expert Rev Anticancer Ther 2011;11:229-49.
20. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009;136:823-37.
21. Klein A, Guhl E, Zollinger R, Tzeng YJ, Wessel R, Hummel M, et al. Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. J Mol Med (Berl) 2005;83:362-76. (Pubitemid 41201801)
22. Kobayashi H, Nagato T, Sato K, Aoki N, Kimura S, Murakami M, et al. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner. Cancer Res 2007;67:5498-504. (Pubitemid 46997291)
23. Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A, et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 2007;96:296-305. (Pubitemid 46160635)
24. Grunewald TG, Kammerer U, Schulze E, Schindler D, Honig A, Zimmer M, et al. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp Cell Res 2006;312:974-82.
25. Helson L, Das SK, Hajdu SI. Human neuroblastoma in nude mice. Cancer Res 1975;35:2594-9.
26. Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, et al. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ Res 2009;104:1169-77.
27. Chappell D, Dorfler N, Jacob M, Rehm M, Welsch U, Conzen P, et al. Glycocalyx protection reduces leukocyte adhesion after ischemia/ reperfusion. Shock 2009;34:133-9.
28. Grunewald TG, von Luettichau I, Welsch U, Dörr HG, Höpner F, Kovacs K, et al. First report of ectopic ACTH syndrome and PTHrP-induced hypercalcemia due to a hepatoblastoma in a child. Eur J Endocrinol 2010;162:813-8.
29. Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, et al. Small round cell sarcomas. Semin Oncol 2009;36: 338-46.
30. Schmidt D, Harms D, Burdach S. Malignant peripheral neuroectodermal tumours of childhood and adolescence. Virchows Arch A Pathol Anat Histopathol 1985;406:351-65. (Pubitemid 15042742)
31. Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, et al. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 2005;65:9226-35. (Pubitemid 41507988)
32. Acharya A, Das I, Chandhok D, Saha T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev 2010;3:23-34.
33. Landriscina M, Maddalena F, Laudiero G, Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 2009;11:2701-16.
34. Nelson KK, Ranganathan AC, Mansouri J, Rodriguez AM, Providence KM, Rutter JL, et al. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003; 9:424-32. (Pubitemid 36109760)
35. Buchberger A, Bukau B, Sommer T. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol Cell 2010;40:238-52.
36. Gorlach A, Klappa P, Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 2006;8:1391-418. (Pubitemid 44726319)
37. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010;142:613-24.
38. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010; 464:1313-9.
39. Yan Q, Dutt S, Xu R, Graves K, Juszczynski P, Manis JP, et al. BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response. Mol Cell 2009;36: 110-20.
40. Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006;25:349-60. (Pubitemid 44354220)
41. Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAKSTAT pathway by reactive oxygen species. Am J Physiol 1998;275: C1640-52.
42. Pan YZ, Li Y, Guo LR, Zhao YY, Zhao XJ. [Influence of expression of six transmembrane epithelial antigen of the prostate-1 on intracellular reactive oxygen species level and cell growth: an in vitro experiment]. Zhonghua Yi Xue Za Zhi 2008;88:641-4.
43. Daiber A. Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta 2010;1797:897-906.
44. Galaris D, Skiada V, Barbouti A. Redox signaling and cancer: the role of "labile" iron. Cancer Lett 2008;266:21-9.
45. Chevion M. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic Biol Med 1988;5:27-37. (Pubitemid 18263724)
46. Grange L, Nguyen MV, Lardy B, Derouazi M, Campion Y, Trocme C, et al. NAD(P)H oxidase activity of Nox4 in chondrocytes is both inducible and involved in collagenase expression. Antioxid Redox Signal 2006;8:1485-96. (Pubitemid 44726325)
47. Johansson N, Ahonen M, Kahari VM. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000;57:5-15. (Pubitemid 30105326)
48. DiMascio L, Voermans C, Uqoezwa M, Duncan A, Lu D, Wu J, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007;178:3511-20. (Pubitemid 46417616)
49. Khodarev NN, Minn AJ, Efimova EV, Darga TE, Labay E, Beckett M, et al. Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res 2007;67:9214-20. (Pubitemid 47535908)
50. Schultz J, Koczan D, Schmitz U, Ibrahim SM, Pilch D, Landsberg J, et al. Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth. Clin Exp Metastasis 2010;27:133-40.